back Back

Millions of depressed Americans could benefit from psilocybin therapy

Sep. 16, 2024.
1 min. read. Interactions

... if FDA approves

About the writer

Amara Angelica

217.93785 MPXR

Electronics engineer, inventor

More than half of patients in the U.S. treated for depression may be eligible for psilocybin-assisted therapy if the FDA approves, according to researchers at Emory University, the University of Wisconsin-Madison and UC Berkeley.

The researchers determined that between 56% and 62% of patients currently receiving treatment for depression—5.1 to 5.6 million individuals—could qualify for psilocybin therapy, if approved.

Citation: Syed F. Rab, Charles L. Raison, and Elliot Marseille. An Estimate of the Number of People with Clinical Depression Eligible for Psilocybin-Assisted Therapy in the United States. 24 September 2024. Psychedelics (Genomic Press, New York) (open-access)

Thumbnail image credit: A. Angelica, DALL E

Let us know your thoughts! Sign up for a Mindplex account now, join our Telegram, or follow us on Twitter

Comment on this content

0 Comments

0 thoughts on “Millions of depressed Americans could benefit from psilocybin therapy

Like

Dislike

Share

Comments
Reactions
💯 💘 😍 🎉 👏
🟨 😴 😡 🤮 💩

Here is where you pick your favorite article of the month. An article that collected the highest number of picks is dubbed "People's Choice". Our editors have their pick, and so do you. Read some of our other articles before you decide and click this button; you can only select one article every month.

People's Choice
Bookmarks